Cosmos Health Inc.
COSM- Exchange
- Nasdaq
- Industry
- Wholesale-Drugs, Proprietaries & Druggists' Sundries
- SEC CIK
- 0001474167
In the last 90 days, Cosmos Health Inc. insiders filed 2 open-market purchases and 0 sales; 21 institutions reported holding it in 13F filings for Q2 2026, worth $389.5K in total; no superinvestor holds it.
Key figures
- Insider buysLast 90 days, $210.0K in total
- 2
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, 0 vs. previous quarter
- 21
- 13F valueReported value at the end of Q2 2026
- $389.5K
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding COSM, Q2 2026
No superinvestor reported holding COSM at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Cosmos Health Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 31, 2026 (view filing)11:52 AM ET | Jul 30 | 1 day | Siokas GrigoriosChief Executive Officer | PPurchaseCommon Stock, par value $.001 | +349.8K | $0.2001 | +$70.0K | +2.5%14.6M after | |
| Jul 30, 2026 (view filing)11:09 AM ET | Jul 29 | 1 day | Siokas GrigoriosChief Executive Officer | PPurchaseCommon Stock, par value $.001 | +766.3K | $0.1827 | +$140.0K | +5.7%14.2M after | |
| Jun 17, 2026 (view filing)9:15 AM ET | Jun 16 | 1 day | Terzis GeorgiosChief Financial Officer | PPurchaseCommon Stock, par value $.001 | +168.1K | $0.2498 | +$42.0K | +8.1%2.24M after | |
| Jun 12, 2026 (view filing)1:22 PM ET | Jun 11 | 1 day | Siokas GrigoriosChief Executive Officer | PPurchaseCommon Stock, par value $.001 | +218.4K | $0.206 | +$45.0K | +1.6%13.5M after | |
| Jun 12, 2026 (view filing)6:20 AM ET | Jun 10 | 2 days | Siokas GrigoriosChief Executive Officer | PPurchaseCommon Stock, par value $.001 | +701.4K | $0.2281 | +$160.0K | +5.6%13.3M after | |
| Feb 13, 2026 (view filing)10:05 AM ET | Feb 12 | 1 day | Siokas GrigoriosChief Executive Officer | PPurchaseCommon Stock, par value $.001 | +388.5K | $0.3732 | +$145.0K | +4.6%8.86M after | |
| Feb 12, 2026 (view filing)2:20 PM ET | Feb 11 | 1 day | Siokas GrigoriosChief Executive Officer | PPurchaseCommon Stock, par value $.001 | +291.3K | $0.412 | +$120.0K | +3.6%8.47M after | |
| Jan 26, 2026 (view filing) | Jan 23 | 3 days | Siokas GrigoriosChief Executive Officer | PPurchaseCommon Stock, par value $.001 | +90.3K | $0.50 | +$45.2K | +1.1%8.18M after | |
| Jan 21, 2026 (view filing) | Jan 20 | 1 day | Siokas GrigoriosChief Executive Officer | PPurchaseCommon Stock, par value $.001 | +353.3K | $0.50 | +$176.7K | +4.6%8.09M after | |
| Jan 15, 2026 (view filing)9:40 AM ET | Jan 14 | 1 day | Siokas GrigoriosChief Executive Officer | PPurchaseCommon Stock, par value $.001 | +493.5K | $0.4458 | +$220.0K | +6.8%7.74M after |
Top 10 13F holders, Q2 2026
The largest institutional positions in Cosmos Health Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| UBS Group AG | 594,462 | $110.0K | 0.00% | +581,728+4,568.3% | Added |
| Vanguard Fiduciary Trust Co | 333,842 | $61.8K | 0.00% | +238,107+248.7% | Added |
| Jane Street Group, LLC | 289,287 | $53.4K | 0.00% | +289,287 | New |
| Geode Capital Management, LLC | 282,094 | $52.1K | 0.00% | −36,017−11.3% | Reduced |
| BlackRock, Inc. | 267,797 | $49.5K | 0.00% | 00.0% | Unchanged |
| Vanguard Capital Management LLC | 173,966 | $32.2K | 0.00% | +33,959+24.3% | Added |
| Northern Trust Corp | 53,887 | $9.95K | 0.00% | +33,333+162.2% | Added |
| State Street Corp | 45,243 | $8.36K | 0.00% | 00.0% | Unchanged |
| Sassicaia Capital Advisers LLC | 36,000 | $6.65K | 0.00% | +36,000 | New |
| Kestra Private Wealth Services, LLC | 13,000 | $2.40K | 0.00% | +13,000 | New |